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Preventing HAPUs in High-Risk Cardiac Cath Patients  
Using Foam Dressing Protocol  
Clinical Leadership Theme 
My Clinical Nurse Leader (CNL) improvement project is entitled Preventing HAPUs in 
High-Risk Cardiac Cath Patients Using Foam Dressing Protocol.  Its clinical leadership theme 
is patient safety, which is one of the six quality dimensions recommended by the Institute of 
Medicine “when working to improve health care” (Nelson, Batalden, & Godfrey, 2007).  A CNL 
is a master’s prepared registered nurse “with a focus on quality improvement and care 
coordination” (Harris, Roussel, Thomas, 2014).  My global aim statement is to improve patient 
safety by preventing hospital-acquired pressure ulcers (HAPUs) in the cardiac catheterization lab 
(CCL).  The process begins at the point of care on admission and ends after a final skin 
assessment is performed and the patient is discharged.  I expect 0% HAPUs for patients 
receiving care in the CCL.    
I chose the following required clinical experience “Work with quality improvement team 
and engage in designing and implementing a process for improving patient safety” as the 
framework for my project (AACN, 2015).  This Systems Analyst/Risk Anticipator competency 
aligns with the clinical leadership theme as the CNL functioning in this role “Participates in 
system reviews Evaluates/anticipates client risks to improve patient safety” (2015).  Additional 
relevant framework competencies include analyzing the microsystem and applying evidence-
based practice.  
Statement of the Problem 
While collecting microsystem data in previous CNL role courses I discovered a 
performance gap that inspired my N653 CNL Internship project.  In spite of having already 
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decreased the total number of HAPUs by 50% in 2015, the CCL was implicated in 30% of those 
reported.  Lengthy procedures such as transcatheter aortic valve replacement (TAVR), 
MitraClip®, Watchman™, and biventricular pacemakers are performed each week in the CCL 
and can last several hours or more.  Once positioned, patients are immobilized and remain supine 
for the duration of the procedure as we are not able to turn or reposition patients intraoperatively, 
subjecting their sacrum and other bony prominences to constant friction and pressure.   
A review of literature established that “All surgical patients should be considered to be at 
risk for pressure injuries, including pressure ulcers” (Cherry & Moss, 2011).  Aside from 
pre/post procedural skin assessments we offer no prophylactic or preventative intervention for 
these individuals who are at high risk for developing HAPUs.  A change in practice is essential 
as Ghavidel, Bashavard, Bakhshandeh Abkenar, and Mehdi Payghambari (2012) report HAPU 
rates post cardiac surgery as high as 21%.  
Project Overview 
In my microsystem we are committed to safety through continuous improvement 
initiatives.  Protecting our members from harm “requires everyone to be involved in identifying 
opportunities where patient care can be made safer” (AHA, 2016).  In order to achieve and 
maintain optimal patient outcomes, “safety must be a property of the system” (IHI, 2016).  
Ultimately my goal is to accomplish safer cardiac catheterization procedures as evidenced by the 
absence of HAPUs.  This project is extremely important because HAPUs are costly (no CMS 
reimbursement for treatment and/or increased length of stay) and there are also legal and 
regulatory implications.  Additionally, “HAPUs are responsible for significant patient harm in 
the form of pain, increased susceptibility to infection, and delayed recovery” (2011).  
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My specific aim is to improve patient safety by reducing the number of HAPUs acquired 
in the CCL to 0% by three months using a prophylactic foam dressing protocol.  It was derived 
from my global aim statement and is the result of failure modes and effects analysis (FMEA), 
process and cause and effect analyses, and evidence-based/best practices (2007).  The 
measurable outcome represents the CCL percentage of total facility HAPUs based on final skin 
assessment prior to discharge.   
Rationale 
Prior to selecting my project I performed a comprehensive needs assessment in order to 
gain a better understanding of my microsystem’s current state and to locate gaps in performance. 
While performing my 5 P’s assessment my preceptor assisted me in obtaining Regional Risk 
Management SB 1301 (Department of Public Health) reports which present monthly HAPU 
incidence at the macrosystem levels.  Further inquiry revealed that the CCL was implicated in 
30% of 2015 HAPUs including two TAVR patients.  This information was subsequently shared 
with the vascular and CCL staff caring for these patients.    
The costs associated with this project are small when compared to its potential savings 
and benefits (see Budget Table in Appendix E).  The amount of money this project will save is 
significant as CMS discontinued reimbursement for HAPUs in 2008 in addition to intangible 
costs such as pain and suffering and organization reputation.  The net benefit (savings) of this 
project using the lower estimate for treatment plus fines for the 30% of HAPUs reported in 2015 
is $187,142.60.   
Methodology 
The objective and specific evidence-based changes in practice involve prospective data 
collection, enhanced skin assessments, and the application of foam dressings in patients deemed 
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high-risk for developing sacral HAPUs and/or those whose procedures are anticipated to last 
three hours or more.  I will personally collect all project data however the latter two changes are 
the responsibility of the microsystem and its professionals.  Patient selection will be 
predetermined based on daily catheterization schedule.  I created an excel spreadsheet to audit 
compliance and track the outcome measure (absence of reportable HAPUs) using my 
organization’s electronic health record, HealthConnect®.                  
I chose Lewin’s change theory for developing my CNL project based on the needs of the 
project itself and the unique characteristics of my microsystem’s professionals, which consists of 
leaders and effective team members.  The discovery of a performance gap necessitated a need for 
change, or unfreezing.  Movement represents PDSA cycles where small tests of change, in this 
case the application of sacral dressings in high-risk patients for HAPU prevention along with 
subsequent skin assessment tracking, are executed and evaluated.  The most significant driving 
force for my project based on SWOT analysis is microsystem support.  Champions emerged as 
expected and immediately began implementing foam-dressing protocol.  Lastly, refreezing is 
when the evidence-based change in practice will become the standard of care.   
As team leader and change agent my first PDSA-Do action will be innovation diffusion 
and selecting/partnering with early adopters.  Other actions include providing transformational 
leadership and collecting, analyzing, and comparing data in order to determine program 
effectiveness.  Patient demographics along with procedure type will be gathered from the 
catheterization schedule.  The patient’s EHR will be used for studying pre/post skin assessments 
for the outcome measure (presence/absence of HAPU).  Based on SWOT analysis I predict 
successful implementation as well as 0% HAPUs for patients receiving care in the CCL by one 
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month.  Outcome measure predictions will be ongoing and compared monthly with expected 
results using Regional Risk Management SB 1301 reports. 
Data Source/Literature Review 
The focus of my study involves Regional Risk Management SB 1301 reports.  These 
reports, accessible only through my preceptor, show monthly HAPU incidence at both the 
regional and facility levels.  This report is particularly appropriate as the CCL was implicated in 
30% of those reported in 2015.  Also, HAPU reporting is mandatory—failure to do so may incur 
fines up to $25,000.00 per incident.  
I began my literature review by formulating the following PICO statements (C represents 
no treatment): In cardiac catheterization patients does using a sacral foam dressing reduce the 
risk HAPUs?  In high risk patients does Mepilex® Border Sacrum reduce HAPU incidence?  I 
utilized the CINAHL Complete database via Gleeson Library to locate relevant sources however 
statement and combination searches retrieved few results.  Determined, I was able to locate a 
multitude of information by searching for PICO items individually.  I found websites such as 
Agency for Healthcare Research and Quality, American Hospital Association, Institute for 
Healthcare Improvement, and Institute of Medicine to be extremely useful as well.   
The literature included in the literature review supports my project’s specific aim and 
evidence-based change in practice: to improve patient safety by reducing the number of HAPUs 
acquired in the CCL to 0% by three months using a prophylactic foam dressing protocol.  It also 
supports the improvement theme, global aim, business case, methodology, change theory, 
implementation, and barriers.  See annotated bibliography for materials used for research 
evidence including current, peer-reviewed journal articles as well as Mepilex® Border Sacrum 
product information.  
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Timeline 
Pilot testing is already in progress as project questionnaire has been distributed and 
dressings are available in each lab.  Formal project implementation and data collection will begin 
in April 2016.  It was decided that dressing application is the responsibility of all microsystem 
professionals.  I will be closely observing PDSA-Do phase as well as collecting, analyzing, and 
comparing all data.  Please see timeline in Appendix F for more detail as well as dates each step 
is due to be completed.    
Expected Results 
As stated in the Clinical Leadership Theme section, I expect 0% HAPUs for patients 
receiving care in the CCL when I compare my data with Regional Risk Management SB 1301 
reports in February 2017.  I base this expectation on overwhelming support for this project 
including physicians, leadership, and all microsystem professionals consisting of leaders and 
effective followers who are more than willing to make patient safety their priority.  Each one 
understands that this is not a just a school project but an evidence-based change in practice that 
will provide safer procedures resulting in zero HAPUs.    
Nursing Relevance 
My facility’s WOCN certified Surgical CNS implemented a similar improvement project 
in perioperative services after a percentage of patients undergoing cardiovascular surgery 
developed HAPUs.  To our knowledge my project is unique in that HAPU prevention has not 
been studied extensively in CCL patients and warrants further research and publication.  My 
project has nursing relevance and contributes to our present understanding of HAPU prevention 
in an understudied microsystem/patient population.  Also, improving patient outcomes is 
important for nurses.  The American Nurses Association Code of Ethics for Nurses With 
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Interpretive Statements states, “Nurses must participate in the development, implementation, and 
review of and adherence to policies that promote patient health and safety, reduce errors and 
waste, and establish and sustain a culture of safety” (ANA, 2016).  
Summary Report 
 As stated previously, the objective of my CNL Internship project was to improve patient 
safety by reducing the number of HAPUs acquired in the CCL to 0% by three months using a 
prophylactic foam dressing protocol.  The actual population encompassed all patients undergoing 
lengthy (estimated three hours or more), complex cardiac catheterization procedures with or 
without anesthesia including chronic total occlusions (CTOs), TAVR, MitraClip®, Watchman™, 
biventricular implanted devices, and/or any patient who might benefit from sacral protection 
based on nursing assessment and/or provider discretion.  The setting included three cardiac 
catheterization labs and one hybrid suite.  
 Methods used to implement project were unchanged from prospectus.  They involved 
prospective data collection, enhanced skin assessments, and the application of foam dressings in 
patients deemed high-risk for developing sacral HAPUs and/or those whose procedures are 
anticipated to last three hours or more.  Baseline data gathered from needs assessment revealed 
that the CCL was implicated in 30% of 2015 HAPUs including two TAVR patients.  A posttest 
was administered to all CCL staff following instruction (see Appendix G).     
 To date 80 patients met procedural inclusion criteria.  All were administered prophylactic 
sacral dressings and subsequently tracked for the outcome measure using EHRs.  As predicted, 
zero patients treated with prophylactic sacral dressing experienced HAPUs based on discharge 
skin assessments.  Post implementation data demonstrated a reduction in the number of HAPUs 
acquired in the CCL from 30% to 0% at eight weeks.  This project is sustainable as dressings are 
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readily available in each lab and implementation is successfully being incorporated into 
workflow.  I conclude that this evidence-based change in practice effectively reduces HAPUs in 
high-risk CCL patients.     
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Appendix A 
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol  
Fishbone Diagram  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient 
Positioning 
Patient 
Factors 
Cycle 
Times 
HAPU 
Formation 
No prophylactic or 
preventative measures 
 
Immobilization 
Difficult and potentially 
unsafe at times 
 
Large patients may put staff 
at risk for injury 
 
Advanced age 
 
Comorbidities 
 
Hemodynamic instability 
 
Nutrition status  
 
Case length highly variable 
based on procedure type 
 
Procedures lasting 3 
hours or more 
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Appendix B 
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol  
Flowchart   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start 
 Final Q&A session/charge meeting 
 Designate champions 
 Develop audit tool 
 Begin pilot test 
 
 Implement PDSA-Do phase 
 Discuss experiences with teams 
 Create Excel tool for data collection   
 Collect compliance data and discharge 
skin assessments for outcome measure 
 Provide feedback 
 Continue PDSA-Do phase 
 Study the data and make changes as 
necessary 
 
Standardize project? 
 Compare project data with Regional 
Risk Management SB 1301 reports 
February 2017 
 Make 
changes as 
necessary 
 
Yes 
No 
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Appendix C  
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol  
SWOT Analysis 
Strengths (Internal) Weaknesses (Internal) 
 Overwhelming support from 
physicians, leadership, and all 
microsystem professionals 
 Direct purchasing of supplies 
 Fully integrated EHR for tracking 
project data 
 Dressings are relatively inexpensive, 
already approved for purchase, and 
easy to apply/remove 
 Positioning of patient for dressing 
placement/removal in certain situations 
(unsafe during mechanical ventilation, 
intra aortic balloon counterpulsation, 
etc.  Also, positioning large patients 
may put staff at risk for injury) 
 
Opportunities (External) Threats (External) 
 Partner with Vascular and 
Interventional Radiology departments 
 Opportunity for enhanced assessment, 
collaboration, and teambuilding 
 Initial skin/risk assessments and 
dressing application/removal will at 
times be provided by adjacent 
microsystems (threat to data collection) 
 Hybrid catheterization lab poses a 
potential threat, as it is located two 
floors above the rest of the 
microsystem 
 
End 
End 
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Appendix D 
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol  
Stakeholder Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Influence 
Interest 
 Unlicensed 
Professionals 
 Laggards 
 Organization 
(regulatory) 
 Physicians 
 Leadership 
  
 Patients 
 Late 
Majority 
 Preceptor 
 Champions 
 Early Adopters 
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Appendix E 
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol  
Budget Table  
Personnel Cost: 
Personnel (0.6 FTE): $15,855 
Non-personnel   
Start-up medical supplies: $1,542 
Total Start-Up Operating Expenses $17,397 
CNL Improvement Project Net Benefit (Savings) $187,142 
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Appendix F 
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing Protocol  
Gantt Chart 2016-2017 
2015 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar 
Task 1 
            
Task 2 
            
Task 3 
            
Task 4 
            
Task 5 
            
Task 6 
            
 
Definitions:  
Task 1: Final Q&A session/charge meeting; designate champions; develop audit tool; begin pilot test. 
Task 2: Implement PDSA-Do phase; discuss experiences with teams; create Excel tool for data collection.   
Task 3: Collect compliance data and discharge skin assessments for outcome measure; provide feedback. 
Task 4: Continue PDSA-Do phase; study the data and make changes as necessary. 
Task 5: Standardize project.  
Task 6: Compare project data with Regional Risk Management SB 1301 reports February 2017.  
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Appendix G 
Preventing HAPUs in High-Risk Cardiac Cath Patients Using Foam Dressing 
Protocol Posttest 
1. True or False CCL patients are high-risk for HAPU based on advanced age, 
comorbidities, and hemodynamic instability. 
2. True or False Foam dressing protocol is appropriate for all CCL patients. 
3. True or False Senate Bill 1301 requires optional reporting of all HAPUs along 
with an administrative penalty not to exceed $25,000. 
4. True or False The Centers for Medicare & Medicaid, The Joint Commission, 
Agency for Healthcare Research Quality, National Quality Forum, and Institute 
for Healthcare Improvement all recognize pressure ulcers as a quality indicator. 
5. True or False Preventing HAPUs enhances the quality of services we provide 
our members. 
6. True or False HAPUs are costly (no CMS reimbursement for treatment and/or 
increased length of stay) and there are also legal and regulatory implications.   
7. True or False The CCL was implicated in 30% of 2015 HAPUs including two 
TAVR patients.   
8. True or False Dressing application is the responsibility of all microsystem 
professionals.  
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Key: True, False, False, True, True, True, True, True 
